268 related articles for article (PubMed ID: 12100857)
1. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
3. Influence of thermal processing on the properties of chlorpheniramine maleate tablets containing an acrylic polymer.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2002 Nov; 7(4):481-9. PubMed ID: 12503529
[TBL] [Abstract][Full Text] [Related]
4. Citric acid as a solid-state plasticizer for Eudragit RS PO.
Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
[TBL] [Abstract][Full Text] [Related]
5. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit RS PO hot-melt extrudates.
Wu C; McGinity JW
Eur J Pharm Biopharm; 2003 Jul; 56(1):95-100. PubMed ID: 12837487
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS.
Zhang F
Drug Dev Ind Pharm; 2016; 42(4):563-71. PubMed ID: 26065535
[TBL] [Abstract][Full Text] [Related]
7. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
Dave VS; Fahmy RM; Bensley D; Hoag SW
Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
[TBL] [Abstract][Full Text] [Related]
8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
9. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
11. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid.
Bruce LD; Shah NH; Malick AW; Infeld MH; McGinity JW
Eur J Pharm Biopharm; 2005 Jan; 59(1):85-97. PubMed ID: 15567305
[TBL] [Abstract][Full Text] [Related]
12. Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes.
Kidokoro M; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2001; 6(2):263-75. PubMed ID: 11417001
[TBL] [Abstract][Full Text] [Related]
13. Properties of sustained-release tablets prepared by hot-melt extrusion.
Zhang F; McGinity JW
Pharm Dev Technol; 1999 May; 4(2):241-50. PubMed ID: 10231885
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
Dave VS; Fahmy RM; Hoag SW
Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
[TBL] [Abstract][Full Text] [Related]
15. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
[TBL] [Abstract][Full Text] [Related]
16. Influence of chlorpheniramine maleate on topical hydroxypropylcellulose films produced by hot-melt extrusion.
Repka MA; McGinity JW
Pharm Dev Technol; 2001 Aug; 6(3):297-304. PubMed ID: 11485171
[TBL] [Abstract][Full Text] [Related]
17. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
Sauer D; McGinity JW
Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
[TBL] [Abstract][Full Text] [Related]
18. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
[TBL] [Abstract][Full Text] [Related]
19. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
Fukuda M; Peppas NA; McGinity JW
J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
[TBL] [Abstract][Full Text] [Related]
20. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
